Inventor

KRUSE CORNELIS G

NL53 patents

⚠️ This page may combine multiple inventors who share the name “KRUSE CORNELIS G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KRUSE CORNELIS G

SOLVAY PHARM BV

4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity

4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity

1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity

4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity

Phenylpiperazines

Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists

Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity

1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity

Piperazine and piperidine compounds

Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition

Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists

4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity

Neurotensin active 2,3,diaryl-pyrazolidine derivatives

Phenylpiperazines

Imidazoline derivatives having CB1-antagonistic activity

Imidazoline derivatives having CB1-antagonistic activity

1 H-imidazole derivatives as cannabinoid receptor modulators

1H-imidazole derivatives as cannabinoid receptor modulators

Phenylpiperazine

Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites

N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs

DUPHAR INT RES

Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives

Phenyl-substituted (N-piperazinyl) methylazoles for treating affections in the central nervous system

Piperazine compounds, their preparation, and methods of using them

Method of treating psychotropic conditions employing substituted piperazine compounds

Benzisoxazole derivatives having d4-antagonistic activity

3-Tetrahydropyridin-4-yl indoles for treatment of psychotic disorders

Piperazine and piperidine compounds

2-aminoquinoline derivatives having d4-agonistic activity

Method for the preparation of erythro vicinal amino-alcohols

Piperazine and piperidine compounds

Phenyl, Pyrrolidin-2-yl substituted pyrroles having antipsychotic properties

Piperazine and piperidine compounds

Method for the preparation of erythro vicinyl amino-alcohols

Method of preparing N-oxo-tetrahydro-β-carbolines

Method of preparing n-oxo-tetrahydro-beta-carbolines

STOIT AXEL

Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition

Heterocyclic compounds with affinity to muscarinic receptors

Heterocyclic compounds with affinity to muscarinic receptors

LANGE JOSEPHUS H M

Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition

Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition

Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists

SOLVAY PHARMACEUTICALS INC

Piperazine and piperidine compounds

Phenylpiperazines

Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity

VAN LOEVEZIJN ARNOLD

Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists

Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists

FEENSTRA ROELOF W

Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition

TERWEL LOUISE

Heterocyclic compounds with affinity to muscarinic receptors

ABBOTT HEALTHCARE PRODUCTS BV

Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists